Betaine - Generic Drug Details

What are the generic drug sources for betaine and what is the scope of patent protection?

Betaine is the generic ingredient in two branded drugs marketed by Eton, Novitium Pharma, and Recordati Rare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for betaine. Three suppliers are listed for this compound.

Summary for betaine

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	3
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	97
Clinical Trials:	28
Patent Applications:	6,937
What excipients (inactive ingredients) are in betaine?	betaine excipients list
DailyMed Link:	betaine at DailyMed

Recent Clinical Trials for betaine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Southern California Institute for Research and Education	PHASE2
University of Nevada, Las Vegas	PHASE4
Xuanwu Hospital, Beijing	PHASE2

See all betaine clinical trials

Pharmacology for betaine

Drug Class	Methylating Agent
Mechanism of Action	Methylating Activity

Anatomical Therapeutic Chemical (ATC) Classes for betaine

A16AA	Amino acids and derivatives
A16A	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for betaine

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eton	BETAINE	betaine	FOR SOLUTION;ORAL	210508-001	Jan 28, 2022	AB	RX	No	No
Novitium Pharma	BETAINE	betaine	FOR SOLUTION;ORAL	214864-001	Nov 23, 2021	AB	RX	No	No
Recordati Rare	CYSTADANE	betaine	FOR SOLUTION;ORAL	020576-001	Oct 25, 1996	AB	RX	Yes	Yes

Market Dynamics and Financial Trajectory for Betaine

Last updated: February 14, 2026

Market Overview

Betaine is an organic compound naturally present in foods such as sugar beets and spinach. Its primary applications include treatment of hyperhomocysteinemia, liver health, and performance enhancement in livestock, as well as potential use in human nutritional supplements.

Current Market Size and Growth

As of 2022, the global betaine market was valued at approximately USD 400 million, with projections reaching USD 700 million by 2027, representing a CAGR of about 11.5% (source [1]). Growth drivers include increasing awareness of liver health, demand for dietary supplements, and expanding use in animal feed.

Segment Breakdown

• Therapeutic Use: Treatment of homocysteine elevation, liver diseases.
• Nutritional Supplements: Energy, performance, and health products for humans.
• Animal Feed: Growth promotant and nutritional additive, especially in poultry and swine industries.

Regional Market Dynamics

• Asia-Pacific: Largest market share (~40%), driven by rapidly growing livestock sectors in China and India.
• North America: Significant due to expanding supplement markets and clinical research.
• Europe: Mature market with focus on functional foods and clinical applications.

Regulatory Landscape

• The U.S. Food and Drug Administration (FDA) recognizes betaine as safe (GRAS) for use in food and supplements.
• European Food Safety Authority (EFSA) permits usage as a supplement ingredient with established safety levels.
• Growing regulatory acceptance facilitates wider adoption in nutraceutical products.

Key Players and Competitive Landscape

Major companies include Ingredion, DuPont, and Flabharvest. Recent trends feature vertical integration, patent filings, and strategic partnerships aimed at expanding clinical evidence and application scope.

Financial Trends and Investment Outlook

• Research and Development: Investment in clinical trials for liver health and metabolic diseases is increasing. Several companies have initiated Phase II trials.
• Market Expansion: Companies are expanding production capacities, with several facilities coming online in China and India to meet regional demand.
• Pricing Trends: Steady, with minor fluctuations based on raw material costs and regulatory factors.
• Profitability: Gross margins for betaine products hover around 20-25%. Operational margins are influenced by manufacturing efficiency and R&D expenses.

Investment Risks and Barriers

• Limited patent protections for natural sources.
• Possible regulatory restrictions in certain jurisdictions addressing dietary supplement claims.
• Competition from alternative methyl donors or compound replacements.

Future Financial Trajectory

• A compound annual growth rate of approximately 11-13% over the next five years is forecasted, driven by rising supplement consumption and animal feed applications.
• Aggressive expansion into clinical therapeutics may diversify revenue streams.
• Raw material costs and regulatory approvals remain key cost and risk factors.

Key Takeaways

• The global betaine market is rapidly expanding, primarily in dietary supplements and animal feed sectors.
• Regional growth varies, with Asia-Pacific leading due to livestock industry expansion.
• Regulatory acceptance remains supportive, with increasing clinical research fueling future applications.
• Financial outlook indicates steady growth, with potential for diversification into therapeutic solutions.
• Industry competition centers on production capacity, application development, and patent strategy.

FAQs

1. What are the main applications of betaine in the pharmaceutical industry?
Betaine is primarily used for treating hyperhomocysteinemia and liver fibrosis. Emerging research explores its role in metabolic syndrome and neurodegenerative conditions.

2. How is betaine produced at scale?
Commercial betaine is mostly derived from natural sources like sugar beets and maize via fermentation or extraction. Synthetic production accounts for a minor share.

3. What factors influence betaine prices?
Raw material costs, fluctuations in feedstock supply, regulatory changes, and demand from supplement and animal feed sectors affect pricing.

4. Is betaine patentable?
Pure betaine is a natural compound and cannot be patented. Patent protections focus on formulations, delivery methods, and therapeutic uses.

5. What regulatory challenges does betaine face?
While recognized as safe, claims related to therapeutic effects require clinical evidence and approval. Variations exist among jurisdictions, affecting market entry.

---

Citations

[1] MarketsandMarkets, "Betaine Market by Application, Source, and Region," 2022.